• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Voice Preservation
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven (Off-Label) Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition and Swallowing
      • Occupational Therapy and Activities of Daily Living
      • Physiotherapy and Mobility
      • Respiratory Care
      • Speech Therapy and Communication
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • AB Science – Masitinib
      • BrainStorm Cell Therapeutics – NurOwn
      • Clene Nanomedicine – CNM-Au8
      • ILB – Tikomed
      • Kadimastem – AstroRx
      • Mitsubishi Tanabe Pharma America – Oral Edaravone
      • Neuronata-R/Lenzumestrocel
      • NeuroSense – PrimeC
      • Neuvivo – NP001
      • Prilenia Therapeutics – Pridopidine
      • SOD1 Therapies & Trials
      • SPG302
      • T Regulatory Cell Therapies
      • Ulefnersen – Ionis Pharmaceuticals
    • Approved Drugs
      • Nuedexta
      • Radicava/Edaravone
      • Riluzole/Tiglutik
      • Rozebalamin/Methylcobalamin
      • Tofersen/Qalsody
    • Drugs No Longer in Development
      • Amylyx – AMX0035
      • Collaborative Medicinal Development – CuATSM
      • Cytokinetics – Reldesemtiv
      • Orphazyme – Arimoclomol
      • TUDCA Trial
  • Support for Health Professionals
    • Breaking the News in ALS/MND
  • Events/Programs
    • Calendar of Events/Programs
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • International Symposium
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • Members
    • Member Registration
    • Forgot Password

Forbes Norris Award

The Forbes Norris Award was established in 1994 to honour the legacy of Dr. Forbes “Ted” Norris (1928–1993), a neurologist who dedicated his life to supporting people living with ALS/MND. This prestigious award recognizes individuals whose work advances clinical care, research, and understanding of ALS/MND for the benefit of those living with the disease.

To be considered for the Forbes Norris Award, candidates must:

  • Play a major role in delivering outstanding ALS/MND patient care
  • Contribute significantly to medical literature in clinical management or basic science related to ALS/MND
  • Be part of a team engaged in ongoing research into ALS/MND care, management, or basic science

The award is presented annually during the opening ceremony of the MND Association’s International Symposium on ALS/MND. If no suitable candidate is nominated in a given year, the award will not be granted. Please note that current Board of Directors are not eligible for nomination.

The 2026 nomination period is open. The deadline to submit your nominations is Tuesday, September 15.

Forbes Norris Award Nomination Form

  • (No self-nominations please)
  • Accepted file types: doc, docx, pdf, Max. file size: 128 MB.
    Please use .doc, .docx, or .pdf
  • This field is for validation purposes and should be left unchanged.

Primary Sidebar

  • Laurie Petit-Jean, France

    Laurie Petit-Jean, France

  • Joyce Rusinak, USA

    Joyce Rusinak, USA

  • Chen Chun-Chin, Malaysia

    Chen Chun-Chin, Malaysia

  • Maria Santos Garcia Tellez, Mexico

    Maria Santos Garcia Tellez, Mexico

  • Mahmood Anwar, UK

    Mahmood Anwar, UK

  • Jay Epstein, USA

    Jay Epstein, USA

  • Orly Dichoso, Canada

    Orly Dichoso, Canada

  • Motoko Ogasawara, Japan

    Motoko Ogasawara, Japan

  • Dr. Janmejay Pradhan, India

    Dr. Janmejay Pradhan, India

  • Osiel Mendoza, USA

    Osiel Mendoza, USA

  • Sally Pauls, USA

    Sally Pauls, USA

  • Jo Knowlton, Scotland

    Jo Knowlton, Scotland

  • Marco Antonio Alvarez Mercado, Mexico

    Marco Antonio Alvarez Mercado, Mexico

  • Rosie Riley, USA

    Rosie Riley, USA

  • Claire Garry, USA

    Claire Garry, USA
    20200117_214643

  • Jette Odgaard Villemoes, Denmark

    Jette Odgaard Villemoes, Denmark

  • Cath Muir, UK

    Cath Muir, UK
    Cath

  • Shay Rishoni, Israel

    Shay Rishoni, Israel

  • Greg Heydet, USA

    Greg Heydet, USA

  • John Sweeney, USA

    John Sweeney, USA

  • Jeff Sutherland, Canada

    Jeff Sutherland, Canada
    jspic

  • Danny Reviers, Belgium

    Danny Reviers, Belgium
    DannyReviers

  • Natalya Rybakova, Russia

    Natalya Rybakova, Russia

  • Sébastien Batiot, France

    Sébastien Batiot, France

  • Anthony Lynch, Australia

    Anthony Lynch, Australia

  • Liam Dwyer, England

    Liam Dwyer, England

  • Oliver Juenke, Germany

    Oliver Juenke, Germany

  • Jean Waters, UK

    Jean Waters, UK

  • Sharon Corosanite, USA

    Sharon Corosanite, USA

  • Alberto Baez Murillo, Colombia

    Alberto Baez Murillo, Colombia

  • Jack Buzby, USA

    Jack Buzby, USA

  • Natalya Rybakova, Russia

    Natalya Rybakova, Russia

  • Malu Araujo Ribeiro, Brazil

    Malu Araujo Ribeiro, Brazil

  • Jason Goodman, USA

    Jason Goodman, USA

  • Magdalena Ayala Rodríguez, Mexico

    Magdalena Ayala Rodríguez, Mexico

  • Animesh Kumar, India

    Animesh Kumar, India

  • Kirsten Harley, Australia

    Kirsten Harley, Australia

  • Dorette Lüdi, Switzerland

    Dorette Lüdi, Switzerland

  • Mikey Stone, ALS

    Mikey Stone, ALS

  • Anderson Custodio Pinto, Brazil

    Anderson Custodio Pinto, Brazil

  • Dick Dayton, USA

    Dick Dayton, USA

  • Denis Blais, Canada

    Denis Blais, Canada

  • Michael Lee, Australia

    Michael Lee, Australia

  • Eddy LeFrançois, Canada

    Eddy LeFrançois, Canada

  • Roxana Canova, Argentina

    Roxana Canova, Argentina

  • Francisco Perez Palop, Spain

    Francisco Perez Palop, Spain

  • Bob Spurrier, USA

    Bob Spurrier, USA

  • Wendy Hendrickson, USA

    Wendy Hendrickson, USA

  • Gisli Jonasson, Iceland

    Gisli Jonasson, Iceland

  • Art Eggert, USA

    Art Eggert, USA

Learn more about the March of Faces

Footer

Stay connected to the global ALS/MND community.

Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

 
This field is for validation purposes and should be left unchanged.
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube
Return to top of page

Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login